TB-500 (Thymosin Beta-4) 10mg Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ (amidated C-terminus)

Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ (amidated C-terminus)

Research Applications (Observational Data from Published Studies) The following points summarize observations reported in scientific literature from preclinical (mostly rodent/rabbit) and early-phase human studies and are provided solely for informational and research-planning purposes:

Preclinical data suggest potential in autoimmune disorder research

Melanotan II administration induced dose-dependent skin tanning via MC1R-mediated eumelanin production

prolonged slow-wave sleep (SWS) duration

TB-500 (Thymosin Beta-4) 10mg Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ (amidated C-terminus)Overview TB 500 is the synthetic, acetylated active fragment (1723) of Thymosin Beta 4, represented by the sequence Ac LKKTETQ. This research peptide is widely studied in laboratory and preclinical environments for its involvement in actin regulation, cellular migration, angiogenesis, tissue remodeling, and inflammatory pathway modulation. Due to its defined active region and smaller molecular size, TB 500 is frequently utilized in in vitro and animal